Podag Tablet 5 mg (Dapagliflozin Propanediol Hydrate)
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
IYON Pharmaceutical Co., Ltd.
MFDS item code 202204351 · Approved 2022.12.05
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to help control blood sugar levels in patients with type 2 diabetes. It can be administered either as monotherapy or in combination with other medications, alongside dietary and exercise treatment. It is especially helpful for patients who have difficulty controlling their blood sugar levels and who have cardiovascular diseases or risk factors. This medication is used to improve blood sugar management and enhance overall health status.
Type 2 diabetes mellitus Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, including insulin. When this medicine is used in combination with insulin or insulin secretagogues such as sulfonylureas, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received antidiabetic drug therapy, the recommended initial dose of this medicine when administered in combination with metformin is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR <45 mL/min/1.73m2: Administration of this medicine is not recommended for the purpose of improving glycemic control. - Patients receiving dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, a starting dose of 5mg is recommended. If well tolerated, this dose may be increased to 10mg. Elderly patients (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.
This medication should not be used in specific patients. For example, patients who are allergic to the active ingredients or additives of this medication, patients with type 1 diabetes or diabetic ketoacidosis, and patients with genetic lactose intolerance problems should not take this medication. Additionally, this medication should not be used in patients undergoing dialysis. In patients with decreased fluid volume or reduced kidney function, this medication should be used with caution. This medication can lower blood pressure and affect kidney function, so the patient’s fluid status and kidney function should be thoroughly evaluated prior to administration, and symptoms of hypotension and changes in kidney function should be periodically monitored after administration. Caution is needed in patients with moderate to severe kidney impairment as the effectiveness in controlling blood sugar levels may be reduced. Using this medication can result in side effects such as genital infections, urinary tract infections, hypoglycemia, decreased fluid volume, and diabetic ketoacidosis. Genital infections occur more frequently in women, and patients who have experienced such infections in the past have a higher risk of recurrence. Hypoglycemia may occur more frequently when used in conjunction with insulin or sulfonylureas, and dose adjustments may be necessary when combined with these medications. Furthermore, during treatment with this medication, dehydration or hypotension symptoms may occur due to decreased fluid volume, so patients should consult healthcare professionals immediately if such symptoms arise. Rarely, serious infections like Fournier's gangrene, which can be life-threatening, have been reported; therefore, if pain, swelling, or redness occurs around the perineum, treatment should be sought immediately. It is advisable for pregnant or breastfeeding women to avoid using this medication. If pregnancy is confirmed, the use of this medication should be discontinued immediately, and it should not be taken while breastfeeding. This medication can interact with other drugs; therefore, caution is necessary when taken with diuretics, insulin, sulfonylureas, etc. Patients should always consult with a doctor or pharmacist before taking any medication, and should seek advice immediately if any unusual symptoms arise during use. Lastly, the safety and efficacy of this medication in children have not been established; thus, it should not be used in minors. In the case of overdose, appropriate treatment should be sought immediately from a medical institution.
Vulvovaginitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, reduced fluid volume, polydipsia, diabetic ketoacidosis, dizziness, constipation, dry mouth, low back pain, dysuria, polyuria, nocturia, vulvar itching, genital itching, elevated hematocrit, decreased renal creatinine clearance at the beginning of treatment, dyslipidemia, increased serum creatinine at the beginning of treatment, elevated blood urea, weight loss, acute pyelonephritis, rash, angioedema, asthenia, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, intracerebral hemorrhage, peripheral artery occlusion, angina, myocardial infarction, bile duct stones, cholangitis, alcoholic liver cirrhosis, depression, suicide attempts, gastric adenocarcinoma, anaphylactic reaction, sensory disturbances, cerebral infarction, nerve compression, sensory loss, headache, dyspepsia, nausea, diarrhea, vomiting, urinary retention, increased alanine aminotransferase, increased aspartate aminotransferase, decreased appetite, thirst, taste disturbances, drowsiness, tension headache, carpal tunnel syndrome, diabetic neuropathy, unconsciousness, neuralgia, peripheral neuropathy, sleep disturbances, syncope, tremor, nasopharyngitis, upper respiratory infection, edema, fever, foreign body sensation, facial swelling, facial pain, warmth, flu-like symptoms, chest pain, fatigue, peripheral edema, generalized edema, hunger, vaginal discharge, menstrual irregularities, itching, urticaria, cold sweat, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, shortness of breath, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyps, tinnitus
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a sealed container. Additionally, it is advisable to avoid extremely hot or cold places and to store it at room temperature between 1°C and 30°C.
Yellow, biconvex, round film-coated tablets
28 tablets/box [(7 tablets/PTP x 4)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
IYON Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Sung IS Co., Ltd.
Dapagliflozin Propanediol Hydrate
Prescription medication
Optus Pharmaceutical Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.